Justices Deny Juno Rehearing Bid After Amgen Cert. Grant
The U.S. Supreme Court has denied a Bristol Myers Squibb unit's bid to revive its certiorari petition in a patent case that had $1.1 billion on the line, about two months...To view the full article, register now.
Already a subscriber? Click here to view full article